What makes Tanasi’s patent pending CBD formulation special?
Posted on October 7th, 2020
There are lots of choices for consumers who want to try CBD (cannabidiol). However, almost all of the companies that offer CBD products are just selling hemp extracts that contain primarily CBD. Tanasi is the only company that offers hemp extracts containing a mixture of CBD and CBDa (cannabidiolic acid) along with other cannabinoids. Our customers are thrilled with the patent pending CBD formulation found in our products and you can check out their unsolicited reviews at tanasi.com.
How did Tanasi develop its CBD formulation?
Tanasi commits to develop the best products backed by research. To achieve our goal we challenged several universities and contract research organizations (CROs) to develop the best CBD product possible. Our research driven product development started with a simple question… Why does CBD work?
Most people use CBD to treat inflammatory conditions, such as muscle and joint aches, including arthritic conditions, or skin irritations, such as skin rashes, dry or itchy skin, dermatitis, and psoriasis. The underlying causes of these conditions are an exacerbated or heightened immune response, and CBD acts as an anti-inflammatory or immunosuppressant agent. We investigated the anti-inflammatory properties of both CBD and the natural non-psychotropic cannabinoids produced by Cannabis hemp plants. The results were quite surprising as we found that almost all of the non-psychotropic cannabinoids have anti-inflammatory properties. Next we compared the non-psychotropic cannabinoids to corticosteroids. Corticosteroids are prescription anti-inflammatory agents that dampen or suppress heightened immune responses. In these experiments we found that CBD and CBDa were amongst the best cannabinoids at suppressing the immune response.
Since CBD and CBDa were so effective, we also examined the ability of a 1:1 CBD:CBDa mixture to suppress the immune response. Our research found that the anti-inflammatory capabilities of the 1:1 CBD:CBDa mixture were better than either CBD or CBDa alone. In fact, the mixture is as effective as dexamethasone, the most potent and widely prescribed corticosteroid for treatment of inflammatory conditions.
What does Tanasi’s CBD formulation mean for consumers?
Prescription corticosteroids can cause numerous negative long-term health effects with prolonged use. Tanasi’s patent pending CBD formulation finally gives people the option of using a plant-derived natural product (nutritional supplement) to treat inflammatory issues. The studies conducted to date have shown that the long-term use of CBD causes no health issues and appears to be completely safe.
People also found that regular CBD usage helps them reduce anxiety, exerts a calming effect, and leads to better uninterrupted sleep. If CBD is an anti-inflammatory agent, how can it reduce anxiety and give people a restful night of sleep? The answer lies with the fact that CBD effects the endocannabinoid system. This system helps regulate the brain, central nervous system, and other systems, such as the immune system. The endocannabinoid system is a complex system, much like the immune system. It functions through the interaction of effector cannabinoid molecules with various cellular receptors. While a lot more research remains to be done in this area, CBD and other Cannabis plant cannabinoids appear to interact with the same receptors the natural cannabinoids that are produced by the endocannabinoid system interact with and thus influence the endocannabinoid system.
Tanasi customers find that Tanasi’s patent pending CBD formulation works very well to help them reduce anxiety and achieve better uninterrupted sleep. Since there are multiple receptors involved in the endocannabinoid system it is very likely that the Tanasi CBD:CBDa formula works better than CBD alone, because CBD and CBDa, being different molecules, affect different receptors in the endocannabinoid system. Again, see the reviews from our customers at tanasi.com.
Related Posts in Press Release
What makes Tanasi’s patent pending CBD formulation special?Read More →
May 13 2020
Tanasi’s International Patent on CBD Research FilesRead More →
Oct 31 2019
GreenWay Herbal Products Announces Tanasi, the First University-Developed, Full-Spectrum Cannabinoid Product LineRead More →
Oct 22 2019